Prospective, Open-Label, Interventional, Single-Center Investigator- Initiated Trial of Combination ICG-Directed Visudyne (verteporfin) Photodynamic Therapy (PDT) and Intravitreal Lucentis (ranibizumab) for Trmt of patients with Neovascular AMD.